Marlene Jantzi

Sr. Manager, Access & Stakeholder Relations, Vaccines, Ontario and National

Marlene Jantzi is a registered nurse with over five years of experience in the vaccine industry, holding progressive roles focused on advancing vaccine policy and access. Her work has centered on the development and implementation of strategies to enhance immunization coverage, patient access to vaccines, and strengthening public confidence in vaccines. Prior to her industry roles, Marlene held leadership positions in local public health in Ontario, overseeing programs in Vaccine Preventable Diseases and Infectious Diseases. Marlene holds a Master of Public Health and Certification in Infection Control (CIC), reflecting her ongoing commitment to evidence-based practice and health systems improvement.


All Sessions by Marlene Jantzi

Printer Friendly Download Full Agenda

Day 1 Oct 28, 2025

11:20 am

PANEL

Immunization Innovation: Rethinking Vaccine Access for a Healthier Future

Canada’s vaccine landscape is evolving but ensuring equitable access across the country’s various jurisdictions is not without its hurdles.

This expert panel will bring together participants with diverse backgrounds and perspectives from Canadian healthcare to share viewpoints, discuss actionable strategies, and explore innovative ideas that could reshape the future of vaccine access.

  • Demystify the patchwork for access: Understand the intricacies of provincial and territorial funding and procurement and how to build more cohesive, nationally aligned access strategies
  • Redefine Value: Explore evolving HTA and value assessment methods for vaccines, and how to measure the broader public health and societal benefits of vaccines for adults and their role in preventive care
  • Expand Access: Tackle the persistent barriers to adult immunization and travel-related vaccines and explore new pathways to broaden coverage.

Whether you’re navigating policy, pricing, or patient access, this session will equip you with the insights and tools to drive meaningful change in vaccine market access across Canada.

Day 2 Oct 29, 2025